1. Stocks
  2. Dr. Reddy's Laboratories Ltd.
  3. Swot
swot-logo

Dr. Reddy's Laboratories Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Dr. Reddy's Laboratories Ltd. has 12 Strengths, 7 Weaknesses, 9 Opportunities and 5 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Upcoming results with Rising Delivery Volumes

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Companies with growing costs YoY for long term projects

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Declining profits every quarter for the past 2 quarters

Low Piotroski Score : Companies with weak financials

Increasing Trend in Non-Core Income

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

Highest FII stock holdings

FII / FPI or Institutions increasing their shareholding

Broker price or reco upgrades in last month

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Recent Broker Downgrades in Reco or Target Price

Red Flags: Firms linked to ongoing regulatory investigations/legal cases

Broker downgrades in price or recommendation in the past one month

MFs decreased their shareholding last quarter

US FDA Warning Letter

Stocks with improving cash flow, with good durability

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)